Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2011. Start Trial.
Date Value
September 30, 2026 37.53M
June 30, 2026 15.55M
March 31, 2026 25.63M
December 31, 2025 6.744M
September 30, 2025 -21.82M
June 30, 2025 -11.50M
March 31, 2025 -30.95M
December 31, 2024 -31.03M
September 30, 2024 -18.95M
June 30, 2024 -9.157M
March 31, 2024 0.8725M
December 31, 2023 6.395M
September 30, 2023 6.753M
June 30, 2023 -17.94M
March 31, 2023 -89.37M
December 31, 2022 -180.58M
September 30, 2022 -207.92M
June 30, 2022 -195.19M
March 31, 2022 -146.04M
December 31, 2021 -66.53M
September 30, 2021 -76.95M
June 30, 2021 -61.43M
March 31, 2021 -44.83M
December 31, 2020 -22.17M
September 30, 2020 7.048M
Date Value
June 30, 2020 16.64M
March 31, 2020 30.49M
December 31, 2019 -11.89M
September 30, 2019 -34.67M
June 30, 2019 -83.49M
March 31, 2019 -123.22M
December 31, 2018 -94.60M
September 30, 2018 -64.62M
June 30, 2018 -42.85M
March 31, 2018 -29.75M
December 31, 2017 -33.20M
September 30, 2017 -51.40M
June 30, 2017 -63.55M
March 31, 2017 -61.33M
December 31, 2016 -71.34M
September 30, 2016 -76.07M
June 30, 2016 -80.48M
March 31, 2016 -96.14M
December 31, 2015 -84.64M
September 30, 2015 -72.40M
June 30, 2015 -68.60M
March 31, 2015 -55.41M
December 31, 2014 -72.30M
September 30, 2014 -95.09M
June 30, 2014 -120.84M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
DBV Technologies SA -191.84M
Akari Therapeutics Plc -12.86M
Cellectis SA -45.36M
Alkermes Plc 227.37M
Alnylam Pharmaceuticals, Inc. 752.13M